Our Science

See how our scientific innovation and expertise can support your inhaled development programme

Find out more

Product development

Tailored inhalation services for you

Track record

Choose a partner to help you succeed

News

Vectura provides update on GSK litigation

19/11/2020

Vectura Group plc (LSE: VEC) (“Vectura”), an industry-leading inhalation CDMO, announces that the United States Court of Appeals for the...

Will Downie’s podcast: “There’s a patient at the end of every piece of work we do…”

08/10/2020

In the latest podcast in our series,  Will Downie, Vectura’s CEO, talks about coping with the COVID crisis, our CDMO...